International OCD Foundation

  • Who We Are
    • About the IOCDF
    • Meet Us
    • How We Help
    • Affiliates and Partners
    • For the Media
    • Contact Us
  • Recovery & Support
    • Living with OCD
    • Join a Livestream
    • Find an OCD Walk
    • Community Events & Programs
    • 30th Annual OCD Conference
    • Books About OCD
    • OCD Newsletter
    • Perinatal OCD
    • Faith and OCD
  • For Professionals
    • Training Institute
    • Advanced Forum on OCD
    • On-Demand Webinars
    • IOCDF Conferences
    • Membership
    • Resource Directory Listings (Add or Update)
    • Resources for Students and Trainees
    • Research Grant Program
    • IOCDF Event Sponsorship
    • Job Listings
  • Our Websites
    • OCD in Kids
    • Hoarding Disorder
    • BDD
    • Anxiety in the Classroom
    • Anxiety in Athletes
  • DONATE
  • Find Help
      • How to Find the Right Therapist
      • Support Groups & Treatment Groups
      • Clinics & Programs
      • Resource Directory: Definitions of Search Terms
      • Find a Therapist of Color
      • Managing OCD in Difficult Times
      • Research Studies
      • Help for Kids
      • Help for Hoarding Disorder
      • Help for Body Dysmorphic Disorder (BDD)
  • Learn More
      • What is OCD?
      • What Causes OCD?
      • How is OCD Treated?
      • Disorders Related to OCD
      • Subtypes of OCD
      • Families and OCD
      • From the Experts
      • OCD Research
      • OCD and Autism
      • Faith and OCD
      • Perinatal OCD
      • Educational Resources
  • Get Involved
      • Donate
      • Explore Ways to Give
      • Find an OCD Walk
      • Attend an IOCDF Conference
      • Join a Community Event
      • Share Your Story
      • Become an Advocate
      • Join a Special Interest Group
      • Watch a Livestream
      • Real OCD Resource Center
      • Take a Survey
      • Shop IOCDF Merchandise
      • Public Policy Advocacy
      • Update Email Preferences

Celecoxib as an adjunct to treatment as usual in childhood-onset OCD: A double-blind randomized controlled trial

Posted June 13th, 2023 by borislitvin & filed under .

PANDAS/PANS is associated with neuroinflammation that leads to sudden and acute OCD symptoms developing in children, seemingly overnight. Non-steroidal anti-inflammatory drugs (NSAIDs) like celecoxib (brand name “Celebrex”) are increasingly recommended… Read more »

Circadian rhythm changes as a predictor of OCD symptom severity and outcome in residential treatment

Posted June 13th, 2023 by borislitvin & filed under .

Problems with sleep — in particular a delayed sleep cycle where a person falls asleep late at night and wakes up in the late morning or early afternoon — have… Read more »

Towards optimal use of internet-delivered interventions for obsessive compulsive disorder

Posted June 13th, 2023 by borislitvin & filed under .

Cognitive behavioral therapy (CBT), including exposure and response prevention (ERP), is a proven and effective treatment for obsessive-compulsive disorder (OCD). However, many people with OCD are unable to access effective… Read more »

Assessing correlates of neuroinflammation in children with PANDAS, obsessive compulsive disorder, and healthy controls using Magnetic Resonance Imaging

Posted June 13th, 2023 by borislitvin & filed under .

Inflammation of the brain is suspected to be present in children with PANDAS, but confirming this hypothesis is difficult. The best tools for revealing brain inflammation expose patients to ionizing… Read more »

Pilot study of the glutamate AMPAR modulator RR-HNK in OCD

Posted June 13th, 2023 by borislitvin & filed under .

Although there are medications that can help people with OCD manage their symptoms, those that are currently available may take up to two to three months to begin working. Additionally,… Read more »

Clinical trial of image-guided low-intensity focused ultrasound pulsation (LIFUP) for the treatment of obsessive compulsive disorder (OCD)

Posted June 13th, 2023 by borislitvin & filed under .

About one in three people with OCD do not get better after trying first-line treatments. For patients with severe, treatment-resistant OCD, Deep Brain Stimulation (DBS) is an effective option, but… Read more »

Identification of peripheral biomarkers of antidepressant response in obsessive compulsive disorder

Posted June 13th, 2023 by International OCD Foundation & filed under .

Although many options are available, many people with OCD who take medication to manage their disorder need to try several different medications before finding one that works. This means months… Read more »

    Recent Posts

    • Welcoming our new and returning IOCDF Advocates: Amplifying Voices for Mental Health
    • 2025 IOCDF Award Winners
    • OCD & bisexuality: Navigating bi-erasure and invalidation
    • The Ballad of Ethan Smith
    • The Unseen Chaotic Choreography

    Your gift has the power to change the life of someone living with OCD!

    Donate Ways to Give
    International OCD Foundation
    PO Box 961029, Boston, MA 02196
    (617) 973-5801 | EIN: 22-2894564
    • Twitter
    • Facebook
    • YouTube
    • Instagram
    • LinkedIn
    • How We Help
    • Contact Us
    • Our Financials
    • For the Media
    • Disclaimer
    • Privacy Policy
    • Our Partners

    Copyright © 2025 International OCD Foundation (IOCDF). All rights reserved